Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Hall of Fame Resort & Entertainment Co (HOFV)
Sector: Financial Services; Industry: Shell Companies

Gordon Pointe Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization or other similar business combination with one or more businesses or assets. Gordon Pointe Acquisition Corp. is the subsidiary of Voyager Holdings II, LLC.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-02-01 Levy Michael S President of Operations Sell 1,634 $1.11 $1,814 No
2022-02-01 Crawford Michael Anthony President and CEO Sell 21,332 $1.11 $23,679 No
2022-01-28 Gould Lisa SVP of Human Resources Sell 6,844 $1.16 $7,918 No
2022-01-28 Graffice Barbara Anne EVP of Public Affairs Sell 6,844 $1.16 $7,918 No
2022-01-28 Muhleman Erica EVP of New Bus. Dev./Marketing Sell 13,686 $1.16 $15,835 No
2022-01-28 Levy Michael S President of Operations Sell 13,686 $1.16 $15,835 No
2022-01-28 Crawford Michael Anthony President and CEO Sell 102,629 $1.16 $118,740 No
2022-01-28 Charnes Tara General Counsel and Secretary Sell 13,686 $1.16 $15,835 No
2021-12-27 Graffice Barbara Anne EVP of Public Affairs Sell 11,144 $1.64 $18,276 No
2021-12-27 Muhleman Erica EVP of New Bus. Dev./Marketing Sell 2,786 $1.64 $4,569 No
2021-12-27 Levy Michael S President of Operations Sell 6,687 $1.64 $10,967 No
2021-12-27 Krom Jason Chief Financial Officer Sell 16,716 $1.64 $27,414 No
2021-12-27 Crawford Michael Anthony President and CEO Sell 221,187 $1.64 $362,747 No
2021-12-27 Charnes Tara General Counsel and Secretary Sell 5,015 $1.64 $8,225 No
2021-09-14 Crawford Michael Anthony President and CEO Buy 20,100 $2.81 $56,481 No
2021-05-18 Crawford Michael Anthony President and CEO Buy 25,000 $3.38 $84,500 Yes
2021-02-12 Crawford Michael Anthony President and CEO Buy 40,000 $2.45 $98,000 No
2021-02-12 Schaefer Kimberly Director Buy 25,000 $2.45 $61,250 No
2021-02-12 Krom Jason Chief Financial Officer Buy 10,000 $2.45 $24,500 No
2021-02-12 Dennis David Director Buy 17,000 $2.45 $41,650 No
2021-02-12 Buzzelli Anthony J. Director Buy 10,000 $2.45 $24,500 No
2020-12-29 Lichter Stuart 10%-Owner, Director Buy 10,813,774 $1.40 $15,139,284 Yes
2020-11-18 Dolan James J. 10%-Owner, Director Buy 60,000 $1.39 $83,400 Yes
2020-11-18 Schaefer Kimberly Director Buy 27,500 $1.39 $38,225 Yes
2020-11-18 Lichter Stuart 10%-Owner, Director Buy 100,000 $1.39 $139,000 Yes
2020-11-18 Holz Karl Director Buy 2,500 $1.39 $3,475 Yes
2020-11-18 Gould Lisa VP of Human Resources Buy 7,000 $1.39 $9,730 Yes
2020-11-18 Crawford Michael Anthony President, CEO Buy 58,500 $1.39 $81,315 Yes
2020-11-18 Charnes Tara General Counsel and Secretary Buy 12,214 $1.39 $16,977 Yes
2020-08-21 Crawford Michael Anthony President, CEO Buy 12,500 $4.50 $56,250 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.